For example, MCM2, MCM5, MCM6 and MCM7 have been reported to be upregulated in cervical epithelium squamous cancers, renal cell carcinomas, hepatocellular carcinomas and esophageal squamous cell carcinomas, leading to poorer prognosis 7-10. This evidence concerns the gene MCM6 and hepatocellular carcinoma.